FABBRI, Leonardo
 Distribuzione geografica
Continente #
NA - Nord America 5.869
AS - Asia 3.726
EU - Europa 1.698
SA - Sud America 608
AF - Africa 111
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.030
Nazione #
US - Stati Uniti d'America 5.728
SG - Singapore 1.340
CN - Cina 963
BR - Brasile 482
VN - Vietnam 443
DE - Germania 322
UA - Ucraina 317
HK - Hong Kong 306
TR - Turchia 210
IT - Italia 191
GB - Regno Unito 181
FI - Finlandia 161
FR - Francia 113
SE - Svezia 110
RU - Federazione Russa 100
JP - Giappone 94
IN - India 74
ID - Indonesia 71
MX - Messico 66
BD - Bangladesh 55
CA - Canada 53
PL - Polonia 48
ZA - Sudafrica 41
AR - Argentina 39
IQ - Iraq 29
AT - Austria 28
ES - Italia 27
NL - Olanda 23
VE - Venezuela 20
EC - Ecuador 19
PK - Pakistan 17
CZ - Repubblica Ceca 16
MA - Marocco 16
AU - Australia 15
KE - Kenya 14
LT - Lituania 14
SA - Arabia Saudita 14
CL - Cile 12
DZ - Algeria 12
PY - Paraguay 12
CO - Colombia 11
PH - Filippine 11
EG - Egitto 9
KR - Corea 9
MY - Malesia 9
UZ - Uzbekistan 9
JO - Giordania 8
BE - Belgio 7
CH - Svizzera 7
IL - Israele 6
IR - Iran 6
LB - Libano 6
PE - Perù 6
TN - Tunisia 6
TW - Taiwan 6
AZ - Azerbaigian 5
IE - Irlanda 5
JM - Giamaica 5
KZ - Kazakistan 5
PT - Portogallo 5
RO - Romania 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
UY - Uruguay 4
AL - Albania 3
BB - Barbados 3
BH - Bahrain 3
BO - Bolivia 3
GE - Georgia 3
GT - Guatemala 3
HN - Honduras 3
NP - Nepal 3
OM - Oman 3
TG - Togo 3
BG - Bulgaria 2
CG - Congo 2
CR - Costa Rica 2
DK - Danimarca 2
KG - Kirghizistan 2
LU - Lussemburgo 2
MK - Macedonia 2
NI - Nicaragua 2
QA - Qatar 2
RS - Serbia 2
SN - Senegal 2
BN - Brunei Darussalam 1
BY - Bielorussia 1
CM - Camerun 1
CY - Cipro 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MT - Malta 1
Totale 12.022
Città #
Singapore 867
Ashburn 667
Fairfield 473
Woodbridge 437
San Jose 367
Santa Clara 325
Jacksonville 303
Hong Kong 299
Beijing 297
Houston 279
Chandler 267
Ann Arbor 189
Wilmington 176
Cambridge 172
Seattle 157
Ho Chi Minh City 151
Los Angeles 151
Izmir 131
Nanjing 99
Council Bluffs 98
Hanoi 96
Princeton 92
Tokyo 92
Munich 83
New York 83
Lauterbourg 79
Helsinki 75
Dallas 65
Buffalo 53
Jakarta 53
São Paulo 51
Mexico City 49
Shanghai 49
Milan 45
Warsaw 43
San Diego 38
Boardman 36
Addison 35
Hefei 35
Tianjin 35
Hebei 31
Nanchang 30
Orem 29
Da Nang 27
Turku 27
Shenyang 25
Changsha 24
Chennai 24
Jiaxing 24
London 22
Bremen 21
Denver 21
Rio de Janeiro 21
Vienna 21
Chicago 20
Dong Ket 20
Johannesburg 20
Montreal 18
Moscow 18
San Mateo 18
Frankfurt am Main 17
Nuremberg 17
Atlanta 16
Baghdad 16
Brooklyn 16
Norwalk 16
Haiphong 15
Toronto 15
Boston 14
Curitiba 14
Falkenstein 14
Phoenix 13
Washington 13
Brasília 12
Dearborn 12
Guangzhou 12
Nairobi 12
Poplar 12
Redwood City 11
San Francisco 11
Ankara 10
Belo Horizonte 10
Brno 10
Campinas 10
Ferrara 10
Manchester 10
Ningbo 10
Philadelphia 10
Can Tho 9
Hangzhou 9
Jinan 9
Krasnodar 9
Mountain View 9
Sydney 9
Taizhou 9
Dhaka 8
Falls Church 8
Jeddah 8
Lahore 8
Miami 8
Totale 8.014
Nome #
Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma 242
CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease 238
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma 234
Association between toluene diisocyanate-induced asthma and DQB1 markers: a possible role for aspartic acid at position 57 231
Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis 207
Three-Year Hospitalization and Mortality in Elderly Smokers with Chronic Obstructive Pulmonary Disease or Chronic Heart Failure 201
Enfisema polmonare: prospettive di terapia 198
CD-4-positive T-lymphocytes infiltrate the bronchial mucosa of patients with Sjogren's syndrome 196
Interleukin-13 and-4 expression in the central airways of smokers with chronic bronchitis 194
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 193
The distribution of Neurokinin-1 and Neurokinin-2 receptors in human central airways 190
Airway smooth muscle biochemistry and asthma 189
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics 183
Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC 182
Increased bronchial responsiveness in primary Sjogren's syndrome. A sign of tracheobronchial involvement 180
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study 180
Helicobacter pylori and chronic bronchitis 179
Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation 177
Asthma progression and mortality: The role of inhaled corticosteroids 175
Inflammatory cells in the bronchial glands of smokers with chronic bronchitis 174
Increased bronchial responsiveness in primary and secondary Sjogren's syndrome 169
Increased xanthine oxidase activity in broncoalveolar lavage fluid from subject with chronic bronchitis 168
An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal 168
Inhaled corticosteroids in COPD: Friend or foe? 167
Anti-inflammatory treatments for asthma: Past, present, future 163
Expression of monocyte chemoattractant protein-1 (MCP-1) and CC chemokine receptor 2 (CCR2B) by purified blood monocytes in smokers with lung cancer. 161
Vasoactive intestinal peptide receptors in the airways of smokers with chronic bronchitis 161
Altri problemi di patologia respiratoria 160
Comparative effectiveness of triple therapy versus dual bronchodilation in COPD 160
Interleukin-6, but not pentraxin 3, predicts adverse clinical outcomes on short-term prognosis of patients with incipient heart failure 159
Oxygen radical production of broncho-alveolar lavage fluid (BALF) from subjects with chronic bronchitis. 159
Differential expression of heme oxygenase (HO)-1 in macrophages of lung tumour and tumour-free lung tissues 157
Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease 156
Increased oxidant-induced clastogenic activity in bronchoalveolar lavage fluid obtained from subjects with chronic bronchitis. 155
Cytoplasmic expression of p21 CIPI/WAF1 is increased in endoalveolar macrophages of smokers. 153
Blood eosinophils for the management of COPD patients? 152
Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease 150
Integrin expression on neutrophils and mononuclear cells in blood and induced sputum in stable asthma 149
Significant correlation between interleukin-10 expression and progression of non-small cell lung cancer through heme oxygenase 149
Current controversies in chronic obstructive pulmonary disease: A report from the global initiative for chronic obstructive lung disease scientific committee 147
Production of superoxide radicals by bronchoalveolar lavage fluid obteined from patients with chronic bronchitis 140
Human leukocyyte antigen associations in occupational asthma induced by isocyanates 138
Inhaled corticosteroid containing combinations and mortality in COPD 138
Prevention of Chronic Obstructive Pulmonary Disease 137
Sonicated serum damages human lymphocyte DNA: a model of free radicals induced cell injury 136
What can we learn from late-onset and occupational asthma? 136
Chronic obstructive pulmonary disease in heart failure: prevalence, therapeutic and prognostic implications. 136
Espression of vasoactive intestinal peptide 1 receptor (VIPR1) in the central airways of smokers 135
Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal 132
Immunization and challenge with toulene diisocyanate decrease tachykinin and calcitonin gene-related peptide immunoreactivity in guinea pig central airways 131
Xanthine oxidase in broncho-alveolar lavage fluid of subjects with chronic bronchitis. 130
Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact 128
Severity of airflow limitation is associated with severity of airway inflammation in smokers 126
Mechanism of occupational asthma 124
Neutrophils and asthma. 123
Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation 123
COPD is a risk factor for squamous cell histotype in smokers who develop nonsmall cell lung cancer. Eur Resp J 2003; 22 Supp.45: 361s. 121
Substance P and neurokinin-A in induced sputum from patients with chronic obstructive pulmonary disease. 120
Very low density lipoproteins mediate DNA damage induced by sonicated serum on human lymphocytes. 118
Mucin expression in the bronchiolar epithelium of patients with chronic obstructive pulmonary disease. 117
Management of chronic refractory cough in adults 117
Similarities between mechanism of superoxide production in ultrasuond treated human serum and in BALF from patients with chronic bronchitis 115
Chronic cough in adults 115
Glucocorticoidi 114
Impact of smoking status and concomitant medications on the effect of high-dose N-acetylcysteine on chronic obstructive pulmonary disease exacerbations: A post-hoc analysis of the PANTHEON study 112
Neutrophils and Asthma 111
Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA 109
Triple therapy for all patients with severe symptomatic COPD at risk of exacerbations 108
CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease 105
Guidelines and recommendations for the clinical use of bronchoalveolar lavage in asthma 103
HLA class II molecules and asthma induced by toleune diisocyanate 103
Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting: Best Practice 102
Evaluation by self-monitoring and noninvasive measures 99
A person-centred clinical approach to the multimorbid patient with COPD 98
Influence of asbestos exposure on heme oxygenase(HO)-1 expression in lung tumour-associated macrophages. 169 (7): A411. 97
Small airway dysfunction: not so silent after all? 95
Subclinical cardiac dysfunction in moderate to severe chronic obstructive pulmonary disease (COPD) patients 85
Inhaled long-acting muscarinic antagonists in asthma - A narrative review 85
Extrafine beclometasone dipropionate/ formoterol fumarate vs double bronchodilation therapy in patients with copd: A historical real-world non-inferiority study 84
Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study 73
Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS 73
Rate of Decline of FEV1 as Biomarker of Survival? 72
Spirometry: A practical lifespan predictor of global health and chronic respiratory and non-respiratory diseases 66
Leveraging Computed Tomography Imaging to Detect Chronic Obstructive Pulmonary Disease and Concomitant Chronic Diseases 65
Sex differences in asthma control, lung function and exacerbations: the ATLANTIS study 58
null 50
null 45
Cluster Analysis to Identify Distinct Asthma Phenotypes in the ATLANTIS Cohort 18
Detecting Small Airways Dysfunction in Asthma: Rationale, Findings, and Future of ATLANTIS 5
Totale 12.177
Categoria #
all - tutte 57.503
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.701
Totale 59.204


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021382 0 0 0 0 0 0 0 0 0 109 148 125
2021/2022797 28 53 49 61 61 25 25 46 36 55 71 287
2022/2023646 78 16 40 79 115 86 36 59 74 3 41 19
2023/2024391 42 48 20 15 25 54 13 25 15 5 11 118
2024/20251.796 38 59 155 47 238 161 29 61 282 224 272 230
2025/20264.989 568 223 437 662 784 358 645 286 538 488 0 0
Totale 12.177